Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Rethinking Second-Line Therapy for Overactive Bladder to Improve Patient Access to Treatment Options.
Obstet Gynecol. 2021 Mar 1;137(3):454-460. doi: 10.1097/AOG.0000000000004279.
Obstet Gynecol. 2021.
PMID: 33543891
Review.
"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder.
Bennett AT, Ringel NE, Menhaji K, Brown OE, Hall EF, Cardenas-Trowers OO, Falk KN, Jeney SES, Barnes H, Escobar C, Tellechea LM, Sappenfield EC, Mehta S, Chang OH.
Bennett AT, et al. Among authors: tellechea lm.
Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):2-4. doi: 10.1097/SPV.0000000000000978.
Female Pelvic Med Reconstr Surg. 2021.
PMID: 33369964
No abstract available.
Item in Clipboard
A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder.
Tellechea LM, Freeman S, Agalliu I, Laudano MA, Suadicani SO, Abraham N.
Tellechea LM, et al.
Metabolites. 2022 Sep 19;12(9):880. doi: 10.3390/metabo12090880.
Metabolites. 2022.
PMID: 36144284
Free PMC article.
Item in Clipboard
Cite
Cite